TOM20 antibodies are tools for studying mitochondrial protein import machinery, mitophagy, and diseases linked to mitochondrial dysfunction. These antibodies target TOM20, a 16–16.3 kDa receptor subunit of the TOM complex that recognizes nuclear-encoded mitochondrial precursor proteins .
Reactivity: Human, Mouse, Rat, Monkey
Applications: WB, IP, IHC, IF
Key Data:
Reactivity: Human, Mouse
Applications: WB, IF
Key Data:
Host: Mouse IgG2a
Conjugates: HRP, PE, FITC, Alexa Fluor®
Key Data:
Mitophagy Assay: TOM20 antibodies quantify mitochondrial clearance in neuronal models (e.g., ReNcell VM cells). Co-treatment with oligomycin/antimycin (O/A) reduces TOM20 immunoreactivity, indicating mitophagy activation .
Parkinson’s Disease: TOM20 overexpression rescues α-synuclein-induced mitochondrial dysfunction, preserving dopaminergic neurons by restoring electron transport chain proteins .
| Antibody | WB | IHC | IF/ICC | IP |
|---|---|---|---|---|
| Proteintech 11802-1-AP | 1:5,000–50,000 | 1:500–2,000 | 1:50–500 | 0.5–4 µg/mg lysate |
| Tom20 (D8T4N) Rabbit mAb | 1:1,000 | 1:50 | 1:100 | 1:50 |
Neurodegeneration: Reduced TOM20 levels correlate with mitophagy defects in Parkinson’s and ALS .
Cancer: TOM20 overexpression in melanoma regulates Bax translocation, influencing pyroptosis .
Perform Blue Native PAGE (BN-PAGE) with isolated mitochondria, followed by immunoblotting using TOM20-4 antibody. Compare migration patterns to known TOM complex subunits (e.g., TOM40 at 34 kDa).
Validate via protease susceptibility assays: Treat intact mitochondria with trypsin before lysis. TOM20-4 signal should disappear due to cytoplasmic domain degradation, while TOM40 remains intact .
Use knockout cell lines or siRNA-mediated TOM20 knockdown as negative controls .
HeLa cells: For single-molecule tracking of TOM20-4 diffusion dynamics using fluorescent protein (FP) tags (e.g., EGFP-Tom20) .
ReNcell VM neuronal models: To assess mitophagy via TOM20 immunostaining intensity under mitochondrial stressors (e.g., oligomycin/antimycin) .
Plant mitochondria: Arabidopsis outer membrane preparations for studying isoform-specific interactions (Table II) .
Always include reducing/non-reducing Western blots to detect oxidation-induced dimerization, as cysteine residues (Cys13/Cys21) alter migration .
Proximity labeling: Use TOMM20-APEX2 constructs to map interactomes under varying metabolic states (e.g., iron stimulation). Compare partners like SYNJBP2 or PABPC4L against negative controls (Mito-APEX2) .
Functional rescue experiments: Express TOM20-4 mutants (e.g., C13S/C21S) in knockdown models. Monitor Bax translocation efficiency and caspase activation .
Epitope mapping: The D8T4N antibody targets a conserved N-terminal region (aa 50–70) across Homo sapiens, Mus musculus, and Arabidopsis .
Validate using:
ReNcell VM protocol:
Normalize to nuclear counts (DAPI) to exclude cytotoxicity confounders.
Single-particle tracking (SPT) in HeLa cells reveals two subpopulations:
Use photoactivatable GFP tags to minimize overexpression artifacts.
Combine orthogonal approaches: Crosslink with formaldehyde before BN-PAGE to stabilize weak interactions.
Under ROS (e.g., FeSO4/CCCP), Cys13/Cys21 form disulfide bonds, altering epitope accessibility .
Non-reducing SDS-PAGE + Western blot confirms oxidation. Always include β-mercaptoethanol controls.
| Isoform | AA Length | Calculated MW (kDa) | pI |
|---|---|---|---|
| TOM20-4 | 187 | 21.0 | 5.4 |